Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA)

Q: What does CUSIP 092667104 represent in this 13F holders report?

CUSIP 092667104 is the security identifier for SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share in Q4 2023?

98 institutional investors reported SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 092667104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Warrants to purchase Class A Common Stock, par value $0.0001 per share
Shares outstanding: 85,979,314
Total 13F shares: 35,332,178
Share change: +985,663
Total reported value: $124,791,578
Put/Call ratio: 112%
Price per share: $3.53
Number of holders: 98
Value change: +$3,955,619
Number of buys: 52
Number of sells: 34

Quarterly Holders Quick Answers

What is CUSIP 092667104?
CUSIP 092667104 identifies SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 092667104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARK Investment Management LLC	13F	Company	7.9%	6,793,726	$17,595,750	—	30 Sep 2023	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	5%	4,260,261	$11,034,076	—	30 Sep 2023	13F
Amova Asset Management Americas, Inc.	13F	Company	5%	4,260,261	$10,991,473	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	4.4%	3,820,390	$9,894,811	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	3.3%	2,817,988	$7,298,590	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	2.4%	2,022,318	$5,237,804	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	1,184,928	$3,069,324	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	— mixed-class rows	1,378,198 mixed-class rows	$1,917,602	—	30 Sep 2023	13F
Northern Right Capital Management, L.P.	13F	Company	0.84%	722,332	$1,870,840	—	30 Sep 2023	13F
Uniplan Investment Counsel, Inc.	13F	Company	0.82%	705,094	$1,847,000	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.71%	607,482	$1,573,378	—	30 Sep 2023	13F
Brandywine Global Investment Management, LLC	13F	Company	0.62%	535,900	$1,387,981	—	30 Sep 2023	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.55%	475,092	$1,230,488	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.54%	466,367	$1,207,890	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.45%	390,199	$1,011,000	—	30 Sep 2023	13F
Cerity Partners LLC	13F	Company	0.43%	372,662	$965,195	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	— mixed-class rows	2,418,195 mixed-class rows	$835,355	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.35%	299,949	$776,868	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.32%	276,488	$716,244	—	30 Sep 2023	13F
Deane Retirement Strategies, Inc.	13F	Company	0.3%	261,258	$677,290	—	30 Sep 2023	13F
Ionic Capital Management LLC	13F	Company	— mixed-class rows	694,496 mixed-class rows	$639,602	—	30 Sep 2023	13F
Intellectus Partners, LLC	13F	Company	0.28%	237,375	$614,801	—	30 Sep 2023	13F
David Zaslav	3/4/5	Director	— class O/S missing	3,127,284	$562,911	—	22 Sep 2021	3/4/5
Walleye Capital LLC	13F	Company	— class O/S missing	2,396,076	$551,337	—	30 Sep 2023	13F
Bouvel Investment Partners, LLC	13F	Company	0.2%	175,161	$453,667	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.2%	172,719	$447,342	—	30 Sep 2023	13F
Quinn Opportunity Partners LLC	13F	Company	0.2%	170,720	$442,165	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.2%	168,333	$435,982	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	158,308	$410,018	—	30 Sep 2023	13F
BARCLAYS PLC	13F	Company	0.16%	136,311	$353,045	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.15%	130,133	$337,044	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	127,162	$329,350	—	30 Sep 2023	13F
Aspen Grove Capital, LLC	13F	Company	0.15%	125,000	$323,750	—	30 Sep 2023	13F
Allen Investment Management, LLC	13F	Company	0.12%	100,000	$259,000	—	30 Sep 2023	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.12%	99,838	$258,580	—	30 Sep 2023	13F
LMR Partners LLP	13F	Company	— class O/S missing	1,031,148	$237,267	—	30 Sep 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	85,827	$222,282	—	30 Sep 2023	13F
UBS Group AG	13F	Company	— mixed-class rows	80,435 mixed-class rows	$208,163	—	30 Sep 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.09%	78,661	$203,732	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	70,105	$181,572	—	30 Sep 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.08%	67,500	$174,825	—	30 Sep 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.06%	55,145	$142,826	—	30 Sep 2023	13F
XTX Topco Ltd	13F	Company	0.05%	40,279	$104,323	—	30 Sep 2023	13F
Focused Wealth Management, Inc	13F	Company	0.05%	39,261	$101,686	—	30 Sep 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.04%	36,499	$94,532	—	30 Sep 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	33,993	$88,042	—	30 Sep 2023	13F
MetLife Investment Management, LLC	13F	Company	0.04%	32,344	$83,771	—	30 Sep 2023	13F
BANK OF MONTREAL /CAN/	13F	Company	0.03%	25,067	$79,212	—	30 Sep 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	30,579	$79,000	—	30 Sep 2023	13F
HighTower Advisors, LLC	13F	Company	0.04%	30,099	$79,000	—	30 Sep 2023	13F

Institutional Holders of Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) as of Q4 2023

As of 31 Dec 2023, Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,332,178 shares. The largest 10 holders included ARK Investment Management LLC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Uniplan Investment Counsel, Inc., and MORGAN STANLEY. This page lists 99 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

101

Q4 2023 holders

Holder diff

-3

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.